About
The Institut Pasteur, through its Drug Discovery & Screening Technological Targeted Action (ATC-DDS), is organizing its 3rd annual Drug Discovery & Screening International Symposium dedicated this year to “Vaccines and Therapeutics”. It will be held on November 14th, 2024 (9am to 4.30pm) at the Institut Pasteur Campus (Auditorium François Jacob).
During this meeting, national and international academic researchers and pharma leaders will discuss the latest innovative Drug Development technologies/methods (e.g. MedChem, immunotherapy, nanobodies, human monoclonal antibodies etc) and challenges to tackle a large variety of diseases including emerging infectious diseases and antimicrobial resistance, among others.
PRE-PROGRAM
The following speakers have already confirmed their presence:
- Benjamin Bardiaux – Bacterial transmembrane systems Laboratory – Institut Pasteur, Paris, France
- Ezio Fok – Lemba Therapeutics – Nijmegen, Netherlands
- Emilie Giraud – Chemogenomic and Biological Screening Platform – Institut Pasteur, Paris, France
- Pierre Lafaye – Antibody Engineering Platform – Institut Pasteur, Paris, France
- Serge Mignani – MedChem at Rhône-Poulenc / Sanofi, Glycovax Pharma & University of Madeira – France
- Xavier Morelli – Integrative Structural and Chemical Biology Laboratory & HITS/IPCdd – High Throughput Screening Facility – CRCM, Marseille, France
- Marco Vignuzzi – A*STAR – Singapore, Singapore
- Hervé Watier – Tours University – Tours, France
Full program will be released soon
REGISTRATION
This international Symposium is open to external participants.
For safety and organization purposes, registrations are free but mandatory : click here to register
–> Deadline for registration : November 8th, 2024 (6pm, Paris time)
A personal ID will be required to access Institut Pasteur campus.
Please note that no registration will be authorized on site on the day of the event.
SCIENTIFIC ORGANIZATION COMMITTEE
Nienke Buddelmeijer, Director of the ATC-DDS & Head of the Cell Shape and Pathogenicity Group – Institut Pasteur, France
Fabrice Agou, Director of the ATC-DDS & Head of the Chemogenomic and Biological Screening Platform – Institut Pasteur, France
CONTACT AND INFORMATION
For any question, please contact Emilie Boutet : emilie.boutet@pasteur.fr